• English
  • 简体中文
Login Register
Current Location: Home > Marketing Drugs(EU) Feedback Help Print
Product No EMEA/H/C/005501
Brand Name Nexviadyme
Nonproprietary Name Avalglucosidase alfa
API Avalglucosidase alfa
ATC Code A16
Indications Nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with Pompe disease (acid α-glucosidase deficiency).
Orphan Drug no
Generics no
Marketing Authorization Holder Sanofi B.V.
Status Authorised(授权)
Authorization Date 2022-06-24
Version 1
Condition Approval no
Exceptions no
Biosimilar no
Details 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息)